Benzoquinone

Benzoquinone

SCHEMBL4450121

O=C1C=CC(=O)C=C1.Oc1ccccc1O.[PbH2]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
HPGD P15428 6/20 0.59
KDM4E B2RXH2 6/20 0.59
TDP1 Q9NUW8 5/20 0.59
HSD17B10 Q99714 5/20 0.59
ALOX15 P16050 5/20 0.59
MAPT P10636 5/20 0.59
RECQL P46063 4/20 0.59
APEX1 P27695 3/20 0.59
BLM P54132 3/20 0.59
POLB P06746 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
CYP3A4 P08684 3/20 0.59
CA2 P00918 3/20 0.59
CA12 O43570 2/20 0.59
CA4 P22748 2/20 0.59
CA14 Q9ULX7 2/20 0.59
NPC1 O15118 2/20 0.59
NFKB1 P19838 2/20 0.59
RAB9A P51151 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoquinone SCHEMBL4443896 0.97 ALDH1A1 (0.62) ALDH1A1HPGDKDM4ETDP1HSD17B10
Benzoquinone SCHEMBL27530006 0.89 TDP1 (0.53) ALDH1A1HPGDKDM4ETDP1HSD17B10
Benzoquinone SCHEMBL8027191 0.87 TDP1 (0.55) ALDH1A1HPGDKDM4ETDP1HSD17B10
Benzoquinone SCHEMBL11668509 0.87 TDP1 (0.55) ALDH1A1HPGDKDM4ETDP1HSD17B10
Benzoquinone SCHEMBL27471771 0.83 CYP3A4 (0.55) ALDH1A1HPGDKDM4ETDP1HSD17B10
Catechol SCHEMBL28084016 0.80
Pyrogallol SCHEMBL25396043 0.80 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ETDP1HSD17B10
Questiomycin B SCHEMBL11060308 0.79 ALOX15 (0.71) ALDH1A1HPGDKDM4ETDP1HSD17B10
Benzoquinone SCHEMBL9052881 0.79 KDM4E (0.44) ALDH1A1HPGDKDM4ETDP1HSD17B10
Catechol SCHEMBL2241272 0.77 ALDH1A1 (0.83) ALDH1A1HPGDKDM4ETDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140378522-A1 UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES PREVENTION, L.L.C. (US) 2014-12-25 US disclosed
US-20090312391-A1 UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES PREVENTION, L.L.C. (US) 2009-12-17 US disclosed
US-20050164911-A1 By administering N-Acetylcysteine (NAC), and/or melatonin; cancer diagnosis by detecting or determining the amount of dopamine metabolites; quinone reductase inducer, lipoic acid or salt, and/or resveratrol or salt may be co-administered PREVENTION LLC 2005-07-28 US disclosed
WO-2003077900-A1 A UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES PREVENTION, L.L.C. (US) 2003-09-25 WO disclosed